Cancer Therapy News and Research

RSS

Six prominent surgeons awarded Honorary Fellowship at Clinical Congress of ACS

Last night Honorary Fellowship in the American College of Surgeons (ACS) was awarded to six prominent surgeons from Germany, England, Thailand, Mexico, and Malaysia during the Convocation ceremony that preceded the official opening of the 2013 Clinical Congress of the American College of Surgeons.

7 Oct 2013

Opinions on shutdown: Both sides have moved to indefensible positions; health law is not 'settled,' finding a 'non-disastrous' debt deal

Acrimony, insults, the government shut down. Time to talk to a wise man, someone from the days when government worked. I turned to the famous Mr. Baker - James A. Baker III. ... The Republicans made a mistake early on with a "maximalist" position on Obamacare - they could not realistically achieve their aim of defunding when the Democrats hold the White House and Senate. But the president's position is a "pretty damn maximalist position itself, and people will say that" (Peggy Noonan, 10/3).

5 Oct 2013

New technique for breast cancer treatment and prevention-injection via nipple

JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention-injection of therapeutics via the nipple.

5 Oct 2013

Dying heart cells are kept alive with spikes of oxygen

In a study published in published in EMBO Molecular Medicine, a Dartmouth researcher found that dying heart cells are kept alive with spikes of oxygen.

5 Oct 2013

Cynvenio launches ClearID Breast Cancer monitoring program

Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.

4 Oct 2013

UCSD surgeons perform first robotic gastrectomy for gastric cancer treatment

Surgeons at UC San Diego Health System have performed the region's first robotic gastrectomy, a potentially lifesaving procedure to remove a section of the stomach after a diagnosis of gastric cancer. Aided by a da Vinci robot, surgeons remove the diseased tissue, perform a delicate reconstruction and remove local lymph nodes for further testing.

3 Oct 2013

Hypertension Drug May Aid Cancer Treatment

...

2 Oct 2013

Esteya system for high precision skin cancer treatment gets FDA clearance

Esteya, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration, enabling medical centers in the United States to offer their patients with skin cancer a new treatment option.

From Elekta 2 Oct 2013

Sheffield Hallam University encourage careers in radiotherapy with a series of open events

Lecturers at Sheffield Hallam University are trying to encourage more young people to consider a career in radiotherapy with a series of open events at hospitals aimed at tackling the increasing demand for patients receiving the treatment.

From Sheffield Hallam University 2 Oct 2013

Nia exercise benefits individuals with breast cancer

Researchers from ProMedica Cancer Institute have released new findings about the benefits of Nia exercise for individuals with breast cancer. Nia is a sensory-based movement practice that heals the body using music and movement.

2 Oct 2013

FDA grants accelerated approval to Perjeta for neoadjuvant treatment of breast cancer

The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-approved drug for the neoadjuvant treatment of breast cancer.

1 Oct 2013

Report: More Hispanic Texans die from cancer than any other cause

More Hispanic Texans die from cancer than any other cause, according to a new report by the Comparative Effectiveness Research on Cancer in Texas research group.

1 Oct 2013

Researchers show that men experience more harm than good from routine PSA screening

Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm than good from routine PSA screening, according to research to be presented on Monday by Professor Mathieu Boniol, at the 2013 European Cancer Congress (ECC2013).

1 Oct 2013

Study shows prevalence of PTSD responses in female patients after cancer treatment

A paper published in the current issue of psychotherapy and psychosomatics provides data concerned with the appropriateness of a diagnosis of post-traumatic stress disorder in women with a diagnosis of cancer.

1 Oct 2013

Biomedical professor receives 2013 Transformative Research Award from NIH

Cancer researchers have been limited by current imaging technology in their ability to detect not only structure and function of tumors, but also tumor cell circulation. A technology proposed by Lihong Wang, PhD, at Washington University in St. Louis, may hold the key to reaching this goal.

1 Oct 2013

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Dementia is a leading cause of death in the United States; however, patients dying with this disease may not receive optimal end-of-life care. ... many of these [nursing home] residents commonly experience burdensome and costly interventions, such as hospital transfers, tube-feeding, and intravenous antibiotics. ... Nursing home reimbursement policies are among the factors that incentivize more aggressive care. ... This study linked unique prospective clinical data with Medicare claims to describe and compare patterns of care between nursing home residents with advanced dementia enrolled in a Medicare managed-care insurance plan and those with fee-for-service Medicare.

30 Sep 2013

Men with prostate cancer experience more harm than good from routine PSA screening

Prostate cancer screening using the prostate-specific antigen test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm than good from routine PSA screening, according to research to be presented today (Monday) by Professor Mathieu Boniol, at the 2013 European Cancer Congress.

30 Sep 2013

Cancer Therapy News and Research

Six prominent surgeons awarded Honorary Fellowship at Clinical Congress of ACS

Opinions on shutdown: Both sides have moved to indefensible positions; health law is not 'settled,' finding a 'non-disastrous' debt deal

New technique for breast cancer treatment and prevention-injection via nipple

Dying heart cells are kept alive with spikes of oxygen

Cynvenio launches ClearID Breast Cancer monitoring program

UCSD surgeons perform first robotic gastrectomy for gastric cancer treatment

Hypertension Drug May Aid Cancer Treatment

Esteya system for high precision skin cancer treatment gets FDA clearance

Sheffield Hallam University encourage careers in radiotherapy with a series of open events

Nia exercise benefits individuals with breast cancer

FDA grants accelerated approval to Perjeta for neoadjuvant treatment of breast cancer

Report: More Hispanic Texans die from cancer than any other cause

Researchers show that men experience more harm than good from routine PSA screening

Study shows prevalence of PTSD responses in female patients after cancer treatment

Biomedical professor receives 2013 Transformative Research Award from NIH

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Men with prostate cancer experience more harm than good from routine PSA screening

Researchers develop new breast cancer screening technique that can reduce false positives

Sister stem cells display considerable differences despite having identical DNA

Mayo Clinic experts to discuss risk factors, screening and treatments for breast cancer

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News